Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Masina
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
ORCID:
0009-0000-0825-8151
Observed ORCID:
0009-0000-0825-8151
OpenAlex ID:
A5117206491
Continuing chemotherapy beyond 6 cycles increases the chances of complete cytoreduction surgery in patients with advanced ovarian cancer
2025
·
Anna Myriam Perrone
, Francesco Mezzapesa
, et al.
·
European Journal of Surgical Oncology
·
7
Is YouTube™ a Reliable Source of Information for the Current Use of HIPEC in the Treatment of Ovarian Cancer?
2025
·
Francesco Mezzapesa
, Elisabetta Pia Bilancia
, et al.
·
Cancers
·
3
PDF
International trends in concurrent hysterectomy at risk-reducing surgery in BRCA1/2 pathogenic variant carriers: a mixed-methods study
2026
·
Tamar A. Gootzen
, Barbara M. Norquist
, et al.
·
American Journal of Obstetrics and Gynecology
·
1
Clinical and Prognostic Relevance of Histologic Transition in Endometriosis- Associated Ovarian carcinoma
2026
·
Anna Myriam Perrone
, Elisa Scarpelli
, et al.
·
Research Square
PDF
Incidental endometriosis and platinum chemosensitivity: a KELIM-based analysis in advanced ovarian cancer
2026
·
Giulia Mantovani
, Camelia Alexandra Coada
, et al.
·
International Journal of Gynecological Cancer
Ovarian cancer with and without endometriosis: insights into histologic patterns and survival in early-stage disease
2026
·
Elisa Scarpelli
, Camelia Alexandra Coada
, et al.
·
International Journal of Gynecological Cancer
Show more works
View as search
Works count:
6
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type